Hello All,
Only 20 days until the Ask Me Anything (AMA) season on the Characterization of Nanoparticles, at 11:00 am ET on January 27th, 2025. This event will be hosted on the dedicated official event thread. Please use this thread to receive and answer questions during the live #AskTheExperts.
The Nanotechnology Community is excited to have a diverse panel of experts ready to share techniques and strategies to characterize different nanoparticles and answer your questions. I will be serving as the moderator for this session. If you have any questions or specific topics of interest, please add them to this post. Likewise, if you have an idea for a future Ask Me Anything or community webinar, please let us know.
Cheers,
Robert Arnold, Ph.D. "Rusty"
Vice Chair, Nanotechnology Community
------------------------------
Robert D. Arnold, Ph.D. "Rusty"
Professor, Director of Research Support & Development
Department of Drug Discovery & Development
Auburn University, Harrison College of Pharmacy
Auburn, AL 36849 U.S.A.
Email:
[email protected]Office: (334) 844-8434
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------
Original Message:
Sent: 01-02-2025 00:31
From: Mitra Mosharraf
Subject: Nanoparticle Characterization AMA on Jan 27th
Hi Annette,
Thank you for your question and interest on this event. I think Stacey is creating a flyer for this event to be formally shared on the AAPS website, but I can share a summary here:
We are excited to invite you to an exclusive Ask Me Anything (AMA) session on the Characterization of Nanoparticles, on 11:00 am ET on January 27, 2025 in the AAPS Community platform.
This unique opportunity will allow you to interact with a panel of community leaders and experts in the field and get answers to your burning questions about nanoparticle characterization!
Nanoparticles are highly useful in drug delivery. However, their characterization presents distinct challenges that require specialized techniques and expertise.
Learning objectives for this session include:
• How to assess nanoparticle stability
• The role of characterization in the development of nanoparticle-based drug delivery systems
• Challenges and advancements in nanoparticle characterization methodologies
------------------------------
Mitra Mosharraf, PhD
HTD Biosystems, CSO
[email protected]
Livermore, CA
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
Original Message:
Sent: 01-01-2025 15:05
From: Annette Bak
Subject: Nanoparticle Characterization AMA on Jan 27th
@Stacey Axler had a post in the AAPS community regarding a nanoparticle AMA. I can't find any other info. Could you please share?
------------------------------
Annette Bak Ph.D., MBA, FAAPS
Executive Director
AstraZeneca
Weston MA
[email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------